Home › Drug Codes › J Codes › J9196 · GEMCITABINE
Updated October 1st, 2026

GEMCITABINE J Code: J9196

Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q4 2026
APC Payment Limit ?
Not published
CMS publishes none for Q4 2026
ASP ?
No current ASP
Not available for Q4 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
4
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
HCPCS Added Date April 1, 2023
Manufacturer Accord
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Multi-Dose
Dosage Form Injection, Solution

About GEMCITABINE

Gemcitabine is a medication aligned to the HCPCS J Code: J9196 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the intravenous route and manufactured by Accord.

According to CMS Drug Use Information: Gemcitabine is used to treat certain types of cancer (including biliary tract, breast, lung, ovarian, pancreatic). It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

4 NDC packages are crosswalked to J9196. Package detail is available to logged-in subscribers.

Login to view 4 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

GEMCITABINE Pricing & Reimbursement

J9196 Private Payer Reimbursement
$5.49 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Gemcitabine 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J9184 Avyxa Pharma Gemcitabine Injection, gemcitabine hydrochloride (avyxa), 200 mg
J9196 Accord Gemcitabine Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg
J9198 Sun Pharma Gemcitabine Injection, gemcitabine hydrochloride, (infugem), 100 mg
J9201 Generic Code (Multiple Manufacturers) Gemcitabine Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

GEMCITABINE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

CMS does not include Gemcitabine (J9196) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9196. Wastage billing guide →

GEMCITABINE Medically Unlikely Edits (MUE)

The most billing units of J9196 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 200 mg.

Practitioner Office & Hospital Outpatient
19 units / day
= 3,800 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

GEMCITABINE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Breast Cancer Non-Small Cell Lung Cancer Ovarian Cancer Pancreatic Cancer
Drug Class
Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Gemcitabine billing and coding guide?
We have not yet identified a manufacturer source of Gemcitabine billing and coding information.
Are there any available Gemcitabine patient assistance programs?
Our team did not identify a source for Gemcitabine patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Gemcitabine prescribing information?
GEMCITABINE prescribing information can be found at the link below: Visit Here →
Where can I find Gemcitabine side effect information?
Information regarding GEMCITABINE's side effects can be found at MedlinePlus Visit Here →
Does billing GEMCITABINE require JZ/JW wastage modifiers?
CMS does not include GEMCITABINE (J9196) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J9196. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.